MAPT and Alzheimer disease: Aβ42 and total and phosphorylated tau protein (p-tauT181) in the CSF are useful markers for the diagnosis of AD, in which Aβ42 concentrations are lower while the tau protein and its phosphorylated form are higher than those in healthy subjects10, 11.